Burning Rock Biotech (BNR) Return on Assets: 2021-2025
Historic Return on Assets for Burning Rock Biotech (BNR) over the last 5 years, with Sep 2025 value amounting to 0.03%.
- Burning Rock Biotech's Return on Assets rose 8.00% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 8.00%. This contributed to the annual value of 0.34% for FY2024, which is 14.00% up from last year.
- Burning Rock Biotech's Return on Assets amounted to 0.03% in Q3 2025, which was up 17.76% from 0.03% recorded in Q2 2025.
- Burning Rock Biotech's Return on Assets' 5-year high stood at 0.03% during Q3 2025, with a 5-year trough of 0.13% in Q2 2024.
- In the last 3 years, Burning Rock Biotech's Return on Assets had a median value of 0.12% in 2023 and averaged 0.10%.
- Its Return on Assets has fluctuated over the past 5 years, first dropped by 4bps in 2022, then rose by 10bps in 2025.
- MRQ analysis of 5 years shows Burning Rock Biotech's Return on Assets stood at 0.08% in 2021, then crashed by 53bps to 0.12% in 2022, then dropped by 1bps to 0.12% in 2023, then soared by 33bps to 0.08% in 2024, then skyrocketed by 66bps to 0.03% in 2025.
- Its last three reported values are 0.03% in Q3 2025, 0.03% for Q2 2025, and 0.06% during Q1 2025.